Search results
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 13 hours agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 11 hours agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 10 hours agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. ...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 13 hours agoNovavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a...
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ...
GuruFocus.com via Yahoo Finance· 20 hours agoPositive Points Novavax Inc (NASDAQ:NVAX) announced a significant global co-development and co-commercialization agreement with Sanofi, expected to generate approximately ...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi By Investing.com
Investing.com· 1 day agoNovavax , Inc. (NASDAQ:NVAX) has entered into a multibillion-dollar global co-development and...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 hours agoNovavax to Participate in BofA Securities 2024 Health Care Conference PR Newswire GAITHERSBURG, Md., May 13, 2024 GAITHERSBURG, Md., May 13, 2024 /PRNewswire/ -- ...
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 4 days agoNovavax (NVAX) delivered earnings and revenue surprises of -0.96% and 7.30%, respectively, for the...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 1 day ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Novavax's Q1 Results Are Overshadowed by Its Sanofi Partnership | The Motley Fool
The Motley Fool· 11 hours agoNovavax (NVAX 47.63%) released its first-quarter earnings report on May 10, and the vaccine-focused biotechnology company's numbers reflected notable progress. Novavax ...